Clean Science & Technology Ltd

Clean Science Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Clean Science & Technology Ltd

₹ 1,372 0.19%
15 Jan - close price
cleanscience.co.in BSE: 543318 NSE: CLEAN
About

Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]

Key Points

Product Portfolio[1]
Company has the largest capacity in the world for their flagship products.
Performance Chemicals
1. MEHQ No.1 in world.
Used as polymerization inhibitor in acrylic acids, acrylic esters, super absorbent polymers (diapers and sanitary pads),Pre-cursor for agrochemical industry.
2. BHA No.1 in world
Used as anti-oxidant in food and feed industry
3. AP No.1 in world
Used in infant food formulations, breakfast cereals and cosmetics
4. TBHQ No.2 in World
Stabilizer in oil industry
5. HALS No.1 in India
HALS 701 is used in water treatment
HALS 770 is used for UV stabilization in a variety of polymers
Pharma & agro Intermediates
1. Guaiacol : No.1 in India & No.2 in World
Pre-cursor to manufacture APIs for cough syrup
Key raw material to produce Vanillin
2. DCC (Dicyclohexyl Carbodiimide) No.1 in India & No.2 in World
Used as reagent in anti-retroviral
3. p-BQ (Para Benzoquinone) No.1 in India & No.2 in World
Intermediate in agrochemical industry
FMCG Chemicals
1. 4-MAP No.1 in world
Used in UV blocker in sunscreens
2. Anisole : No.1 in world
Precursor to perfumes, insect pheromones, pharmaceuticals
Majority of Anisole produced is used for captive consumption

Website BSE NSE
  • Market Cap ₹ 14,582 Cr.
  • Current Price ₹ 1,372
  • High / Low ₹ 1,690 / 1,243
  • Stock P/E 52.7
  • Book Value ₹ 125
  • Dividend Yield 0.36 %
  • ROCE 29.7 %
  • ROE 22.2 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.3%
  • Company has been maintaining a healthy dividend payout of 18.0%

Cons

  • Stock is trading at 11.0 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE 250 SmallCap Index Nifty MidSmallcap 400 BSE 500 Nifty 500 BSE MidCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
153 181 205 234 248 237 217 188 181 195 225 217 228
84 105 121 143 150 129 112 112 106 108 127 120 133
Operating Profit 69 76 84 91 98 108 105 77 76 86 99 98 95
OPM % 45% 42% 41% 39% 39% 46% 49% 41% 42% 44% 44% 45% 41%
9 7 7 11 3 12 12 12 5 8 13 10 10
Interest 0 0 0 0 0 0 0 0 0 0 1 0 0
Depreciation 6 6 7 8 9 9 10 11 11 11 11 11 11
Profit before tax 71 78 84 94 92 112 108 78 69 83 101 96 94
Tax % 25% 25% 26% 25% 26% 25% 25% 25% 25% 25% 26% 25% 28%
54 58 62 70 68 84 81 59 52 62 75 72 67
EPS in Rs 5.04 5.46 5.88 6.63 6.42 7.90 7.62 5.51 4.89 5.87 7.04 6.79 6.35
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
140 191 241 393 419 512 685 936 789 866
92 118 168 256 234 253 385 533 452 488
Operating Profit 48 72 73 137 186 260 300 403 338 378
OPM % 34% 38% 30% 35% 44% 51% 44% 43% 43% 44%
2 4 5 11 11 25 30 39 38 41
Interest 3 0 1 0 0 0 0 1 1 1
Depreciation 6 6 8 11 14 17 25 36 44 44
Profit before tax 41 70 70 137 182 267 305 405 331 373
Tax % 34% 33% 30% 28% 23% 26% 25% 25% 25%
27 47 49 98 140 198 229 304 248 277
EPS in Rs 192.41 330.79 343.72 690.82 1,051.82 18.68 21.52 28.57 23.31 26.05
Dividend Payout % 13% 12% 12% 15% 2% 134% 15% 18% 21%
Compounded Sales Growth
10 Years: %
5 Years: 15%
3 Years: 15%
TTM: 5%
Compounded Profit Growth
10 Years: %
5 Years: 20%
3 Years: 8%
TTM: 1%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -19%
1 Year: -9%
Return on Equity
10 Years: %
5 Years: 33%
3 Years: 29%
Last Year: 22%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 1 1 1 1 1 11 11 11 11 11
Reserves 99 143 186 271 341 529 758 1,008 1,205 1,314
12 0 1 3 3 0 0 1 1 1
27 35 48 53 85 120 156 139 154 175
Total Liabilities 139 179 236 328 430 660 925 1,159 1,371 1,501
64 77 101 126 166 186 296 427 401 382
CWIP 0 2 1 4 3 55 44 4 2 3
Investments 1 32 18 76 134 233 247 428 666 790
75 68 115 122 127 187 338 300 302 326
Total Assets 139 179 236 328 430 660 925 1,159 1,371 1,501

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
69 45 85 160 193 127 299 277
-52 -17 -94 -106 -186 -124 -245 -228
-15 -5 -11 -55 -6 -0 -55 -53
Net Cash Flow 2 23 -20 -1 1 4 -0 -3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 68 41 60 55 61 53 82 58 75
Inventory Days 246 165 93 79 98 156 143 122 146
Days Payable 79 73 85 48 101 180 166 90 124
Cash Conversion Cycle 235 134 69 87 58 29 59 89 97
Working Capital Days 131 64 61 65 35 32 90 66 78
ROCE % 55% 42% 59% 59% 61% 47% 45% 30%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
78.51% 78.51% 78.51% 78.50% 78.50% 78.50% 74.98% 74.98% 74.98% 74.98% 74.98% 74.97%
5.05% 5.18% 4.43% 4.43% 3.99% 3.99% 5.84% 6.01% 5.92% 5.88% 6.05% 5.83%
4.28% 4.02% 4.51% 4.48% 4.65% 4.76% 6.41% 5.23% 5.13% 5.04% 4.55% 4.77%
12.16% 12.29% 12.55% 12.58% 12.86% 12.74% 12.78% 13.79% 13.98% 14.11% 14.42% 14.43%
No. of Shareholders 2,42,6422,63,5932,70,4462,70,6162,75,1022,70,8232,66,9712,85,2592,78,6532,79,3952,73,8412,54,629

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls